Beurs gesloten -
Swiss Exchange
17:30:28 26-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2,058
CHF
|
+1,38%
|
|
+0,39%
|
-2,65%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
3.929
|
4.248
|
3.298
|
2.383
|
376,8
|
370,4
|
-
|
-
|
Bedrijfswaarde
1 |
3.769
|
3.828
|
4.290
|
3.367
|
376,8
|
1.418
|
1.585
|
1.677
|
K/w-verhouding
|
-7,96
x
|
-8,21
x
|
-4,94
x
|
-2,87
x
|
-1,27
x
|
-1,38
x
|
-1,77
x
|
-3,08
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
164
x
|
59
x
|
94,2
x
|
24,6
x
|
2,48
x
|
3,52
x
|
1,79
x
|
0,92
x
|
Bedrijfswaarde/omzet
|
157
x
|
53,2
x
|
123
x
|
34,7
x
|
2,48
x
|
13,5
x
|
7,68
x
|
4,17
x
|
Bedrijfswaarde/EBITDA
|
-8,16
x
|
-9,79
x
|
-7,21
x
|
-4,57
x
|
-0,78
x
|
-4,06
x
|
-5,63
x
|
-32,7
x
|
Bedrijfswaarde/FCF
|
-7,02
x
|
-10,2
x
|
-6,87
x
|
-3,84
x
|
-
|
-2,86
x
|
-4,12
x
|
-
|
FCF Yield
|
-14,2%
|
-9,77%
|
-14,5%
|
-26%
|
-
|
-35%
|
-24,3%
|
-
|
Price to Book
|
22,8
x
|
6,24
x
|
31,7
x
|
-3,61
x
|
-
|
-0,36
x
|
-0,45
x
|
-0,52
x
|
Aantal aandelen (in duizenden)
|
131.235
|
166.466
|
176.955
|
177.543
|
178.261
|
179.972
|
-
|
-
|
Referentieprijs
2 |
29,94
|
25,52
|
18,64
|
13,42
|
2,114
|
2,030
|
2,030
|
2,030
|
Datum van publicatie
|
6/02/20
|
4/02/21
|
8/02/22
|
7/02/23
|
21/05/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
24
|
72
|
35
|
97
|
152
|
105,4
|
206,5
|
402
|
EBITDA
1 |
-462
|
-391
|
-595
|
-737,2
|
-482
|
-349,3
|
-281,7
|
-51,26
|
Bedrijfsresultaat (EBIT)
1 |
-482
|
-411
|
-613
|
-757
|
-501
|
-358,4
|
-345,5
|
-137,4
|
Operationele Marge
|
-2.008,33%
|
-570,83%
|
-1.751,43%
|
-780,41%
|
-329,61%
|
-340,15%
|
-167,33%
|
-34,17%
|
Resultaat voor belastingen (EBT)
1 |
-485
|
-449
|
-634,8
|
-820,1
|
-294
|
-393,6
|
-366,7
|
-158,9
|
Nettowinst (verlies)
1 |
-494
|
-445
|
-635
|
-828
|
-298
|
-380,2
|
-355,8
|
-153,9
|
Nettomarge
|
-2.058,33%
|
-618,06%
|
-1.814,29%
|
-853,61%
|
-196,05%
|
-360,79%
|
-172,32%
|
-38,29%
|
WPA
2 |
-3,760
|
-3,110
|
-3,770
|
-4,670
|
-1,670
|
-1,467
|
-1,148
|
-0,6593
|
Free Cash Flow
1 |
-536,8
|
-373,9
|
-624
|
-875,7
|
-
|
-496
|
-384,8
|
-
|
FCF-marge
|
-2.236,86%
|
-519,35%
|
-1.782,86%
|
-902,81%
|
-
|
-470,69%
|
-186,34%
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
6/02/20
|
4/02/21
|
8/02/22
|
7/02/23
|
21/05/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
13
|
5
|
5
|
17
|
21
|
54
|
21
|
30
|
80
|
22
|
10,06
|
112,3
|
13,35
|
21,09
|
52,45
|
EBITDA
|
-
|
-224
|
-187,8
|
-207
|
-189
|
-174,3
|
-193
|
-173
|
-37
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-234
|
-228
|
-193
|
-212
|
-193
|
-180
|
-198
|
-177
|
231
|
-115
|
30,94
|
-16,49
|
-121,5
|
-124,1
|
-80,4
|
Operationele Marge
|
-1.800%
|
-4.560%
|
-3.860%
|
-1.247,06%
|
-919,05%
|
-333,33%
|
-942,86%
|
-590%
|
288,75%
|
-522,73%
|
307,63%
|
-14,68%
|
-909,78%
|
-588,48%
|
-153,29%
|
Resultaat voor belastingen (EBT)
|
-
|
-253
|
-196
|
-222
|
-216
|
-190,3
|
-212
|
-192
|
225
|
-116
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
-223
|
-252
|
-198
|
-222
|
-216
|
-193
|
-212
|
-193
|
224
|
-117
|
-
|
-
|
-
|
-
|
-
|
Nettomarge
|
-1.715,38%
|
-5.040%
|
-3.960%
|
-1.305,88%
|
-1.028,57%
|
-357,41%
|
-1.009,52%
|
-643,33%
|
280%
|
-531,82%
|
-
|
-
|
-
|
-
|
-
|
WPA
2 |
-1,340
|
-1,460
|
-1,120
|
-1,250
|
-1,220
|
-1,090
|
-1,190
|
-1,080
|
0,9600
|
-0,6500
|
0,1300
|
-0,1000
|
-0,4100
|
-0,3000
|
-0,2000
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27/07/21
|
8/02/22
|
26/04/22
|
26/07/22
|
25/10/22
|
7/02/23
|
25/04/23
|
25/07/23
|
24/10/23
|
21/05/24
|
21/05/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
991
|
984
|
-
|
1.047
|
1.215
|
1.307
|
Nettokaspositie
1 |
160
|
421
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-1,666
x
|
-1,335
x
|
-
|
-2,998
x
|
-4,314
x
|
-25,5
x
|
Free Cash Flow
1 |
-537
|
-374
|
-624
|
-876
|
-
|
-496
|
-385
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-118%
|
-103%
|
-167%
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-32,1%
|
-39,4%
|
-65,5%
|
-
|
-68,4%
|
-50,9%
|
-9,77%
|
Totale activa
1 |
-
|
1.385
|
1.611
|
1.264
|
-
|
555,7
|
699,5
|
1.575
|
Nettoactief per aandeel
2 |
1,310
|
4,090
|
0,5900
|
-3,720
|
-
|
-5,630
|
-4,530
|
-3,900
|
Cashflow per aandeel
2 |
-3,520
|
-2,550
|
-3,500
|
-4,840
|
-
|
-2,780
|
-3,140
|
-2,090
|
Capex
1 |
18,8
|
9,27
|
25,5
|
16,6
|
-
|
12,5
|
21,3
|
64,5
|
Capex/omzet
|
78,34%
|
12,87%
|
72,93%
|
17,13%
|
-
|
11,82%
|
10,29%
|
16,04%
|
Datum van publicatie
|
6/02/20
|
4/02/21
|
8/02/22
|
7/02/23
|
21/05/24
|
-
|
-
|
-
|
Gemiddeld advies Onderwogen Laatste slotkoers
2,058
CHF Gemiddelde koersdoel
1,692
CHF Spread / Gemiddelde doel -17,76% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -2,65% | 409 mln. | | +16,49% | 122 mld. | | +21,73% | 116 mld. | | +22,18% | 27,03 mld. | | -21,81% | 20,36 mld. | | -16,89% | 16,43 mld. | | -18,81% | 15,91 mld. | | -44,74% | 15,6 mld. | | +62,72% | 14,94 mld. | | +3,09% | 13,59 mld. |
Biotherapeutische geneesmiddelen
|